1. Stocks
    2. /
  2. Telix Pharmaceuticals (ASX: TLX)
    3. /

Telix Pharmaceuticals (ASX: TLX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Telix Pharmaceuticals Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Telix Pharmaceuticals (ASX: TLX)
    Latest News

    Three exuberant runners dash towards the camera. One raises her arms in triumph; another jumps in the air with arms raised. The third runner gives a satisfied smile.
    Growth Shares

    3 hypergrowth ASX shares to buy in 2024 and beyond

    | Tony Yoo

    If you're willing to accept some higher risk, these rapidly expanding companies could be worth a long-term chance.

    Read more »

    medical asx share price represented by doctor giving thumbs up
    Healthcare Shares

    Buy this ASX 200 biotech stock for a 20%+ return

    | James Mickleboro

    Big returns could be on the cards for owners of this share according to analysts.

    Read more »

    A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
    Share Market News

    5 things to watch on the ASX 200 on Monday

    | James Mickleboro

    The Australian share market looks to have run out of steam on Monday.

    Read more »

    Businessman smiles with arms outstretched after receiving good news.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was an absolutely delightful end to the trading week this Friday.

    Read more »

    A woman in a hammock on her laptop and drinking a smoothie
    Investing Strategies

    $9,000 in savings? Here's how I'd try to turn that into $516 a month of passive income

    | Tony Yoo

    It's not massively complicated, but the plan requires some discipline and patience. Are you ready?

    Read more »

    Ordinary Australians waiting at the bus stop using their phones to trade ASX 200 shares today
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    The ASX 200 somehow managed to snatch a gain this Tuesday.

    Read more »

    Shot of a young scientist using a digital tablet while working in a lab.
    Share Gainers

    If you'd put $20,000 in this ASX healthcare stock during COVID-19, you'd have $257,000 now

    | Tony Yoo

    You could have become filthy rich in just 4 years. Just think about that.

    Read more »

    A neon sign says 'Top Ten'.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a mildly positive start to the trading week for ASX shares today.

    Read more »

    Shot of a scientist using a computer while conducting research in a laboratory.
    Healthcare Shares

    The market is placing 'zero value' on this ASX 200 stock's booming pipeline

    | Bernd Struben

    Up 78% in a year, these experts reckon there’s more outperformance to come from this top ASX 200 stock.

    Read more »

    Man with rocket wings which have flames coming out of them.
    Growth Shares

    2 ASX stock picks with explosive potential

    | Tony Yoo

    In return for more risk, you could buy some stocks that have catalysts just lined up over the next few…

    Read more »

    Person pointing at an increasing blue graph which represents a rising share price.
    Growth Shares

    2 top ASX growth shares to buy right now and hold for the long term

    | Tony Yoo

    One stock has returned 1,500% over the past 5 years and the other has tripled in just 19 months.

    Read more »

    Friend enjoying a meal at a restaurant, symbolising passive income.
    Investing Strategies

    How I'd invest $300 a month in ASX shares to target $22,000 annual passive income!

    | Tony Yoo

    Here are three growth stocks that I'd start with to eventually generate a nice cash flow in addition to your…

    Read more »

    Frequently Asked Questions

    No, Telix does not pay dividends at this time. 

    Telix Pharmaceuticals Ltd listed on the ASX on 15 November 2017.

    TLX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Telix Pharmaceuticals

    Telix Pharmaceuticals Ltd (ASX: TLX) is a commercial-stage biopharmaceutical company focused on the ongoing development of diagnostic and therapeutic ('theranostic') products using targeted radiation. This process treats cancerous or diseased cells, an alternative approach to many cancer therapies which also attack healthy tissue at the same time.

    Telix has received global regulatory approvals from the Australian Therapeutic Goods Administration (TGA), the US Food and Drug Administration (FDA), and Health Canada for its prostate cancer imaging agent Illuccix. It is working to get Illuccix approved for sale in the UK and Europe. 

    The company also has more than 20 clinical trials underway worldwide. Telix's research and development is focused on prostate, renal (kidney), glioblastoma (brain), and hematologic (bone marrow conditioning) cancers, as well as rare diseases. The company is headquartered in Australia with offices in Belgium, Japan, Switzerland, and the United States. 

    Profile

    since

    Note